Skip to main content
. 2015 Feb 28;33(9):585–589. doi: 10.1016/j.eimc.2015.01.008

Table 2.

Summary of clinical and demographic data of the five EV-D68-confirmed cases of the present study.

Patient Strain name Birth date (age) Gender Admission date Collection date Sample material Underlying disease Symptoms UCI admission (days) Infection type Coinfection Outcome
Patient 1 VH110070195 01/08/1945
(69 years)
Male 03/06/2014 02/10/2014 TA Bronchoaspiration Bronchorrhea No HA Pseudomonas aeruginosa, Candida albicans, Candida glabrata D
Patient 2 VH110073590 30/08/2014
(1 month)
Female 30/08/2014 10/10/2014 NPA Prematurity Rhinorrhea No HA No D
Patient 3 VH100096404 18/04/2014
(5 months)
Female 10/10/2014 10/10/2014 NPA No Bronchiolitis Yes (10 days) CA Human Parainfluenza-4, Branhamella catarrhalis D
Patient 4 VH110075023 30/08/2014
(1 month)
Female 30/08/2014 14/10/2014 NPA Prematurity Rhinorrhea No HA No D
Patient 5 VH110078432 05/05/1955
(59 years)
Female Outpatient 22/10/2014 BAL Lung transplant Decreased lung capacity no CA Pseudomonas aeruginosa, Granulicatella adiacens D

Abbreviations: TA, tracheal aspirate; NPA, nasopharyngeal aspirate; BAL, bronchoalveolar lavage; HA, hospital-acquired; CA, community-acquired; D, discharged.